According to a new study published in the International Journal of Biological Macromolecules, modified protein used in COVID-19 injections could possibly aid cancer development. “Mounting evidence indicates that these vaccines, like some others, do not generate sterilizing immunity, leaving people vulnerable to recurrent infections. Additionally, it has been discovered that the mRNA vaccines inhibit essential immunological pathways, thus impairing early interferon signaling, ” the researchers wrote. “Within the framework of COVID-19 vaccination, this inhibition ensures an ideal spike protein synthesis and a reduced defense activation. Evidence is provided that adding 100 % of N1-methyl-pseudouridine ( m1Ψ ) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development, ” the researchers continued. “Evidence is provided that adding 100 % of N1-methyl-pseudouridine ( m1Ψ ) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer … pic. twitter. com/kXKE2rXp4f— Chief Nerd (@TheChiefNerd ) April 20, 2024“Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100 % m1Ψ modification, but rather ones with the lower percentage of m1Ψ modification to avoid immune suppression, ” the researchers wrote. According to The Epoch Times, various body responses are triggered by modified and natural RNA. Modified RNA tends to produce more pathological proteins, likely contributing to cell genome instability. The body produces a more subdued response than normal RNA, which may have a significant impact on how well the body functions in fighting against other diseases and cancers. The authors cited studies finding that organic RNA tended to stimulate the activity of type-1 interferon—a important anti-tumor substance—and another defense chemicals. Contrary to popular belief, modified RNA only causes a milder response and is linked to immune cells that promote unusual RNA injection tolerance. A previous study discovered that RNA containing modified uridine failed to activate a process known to be responsible for detecting zoonotic infections and combating cancers. Additionally, they cited Ms. Kariko and Dr. According to Weismann’s study, mRNA modification prevented defense recognition and activation. The authors argue that this was a double-edged sword, according to wide-reaching defensive consequences. A mouse study in Thailand was a crucial piece of evidence that the reviewers cited. Researchers in the study administered 100 percent modified RNA and normal mRNA to two distinct melanoma-positive groups of mice. The body had a stronger immune response when given a healthy RNA injection, according to the Thai researchers. However, the prognosis of the melanoma mice also differed. Without modified RNA, the survival rate in the mice group was 100 %. Likewise, in the group with the modified uridine, only half of the mice survived. The Thai researchers stated in their intangible that an mRNA vaccine causes type-1 interferon production and downstream signals essential for regulating tumor growth and metastasis. ReviewReviewResearchers claim that modification to mRNA in COVID Vaccines may contribute to cancer development. https ://t. co/Q8qM0utXDi— The Epoch Times ( @EpochTimes ) April 22, 2024BREAKING: A review in the International Journal of Biological Macromolecules has found that COVID-19 mRNA vaccines could aid cancer development. The researchers advise against using particular mRNA vaccines in upcoming clinical trials to prevent defense suppression. Wow. — Dr. Simone Gold ( @drsimonegold ) April 16, 2024From ScienceDirect :m1Ψ use in COVID-19 mRNA vaccinesm1Ψ was added in 2020 to Pfizer-BioNTech’s COVID-19 mRNA candidate vaccine ( Comirnaty® or BNT162b2 ), which codes for the entire transmembrane spike ( S ) protein of SARS-CoV-2 [36]. A significant amount of m1Ψ-modified SARS-CoV-2 ( COVID-19 ) spike mRNA was generated by extensive IVT. The Pfizer vaccine became the first mRNA vaccine to be fully licensed after demonstrating a favorable safety record and 95 percent disease protection from the disease after a two-inoculation protocol ( intramuscular injection ). It was crucial to reduce the disintegration of this created mRNA as well as its immunogenicity in order to avoid an overly aggressive immune response. The creators of the mRNA vaccines against SARS-CoV-2 have emphasized only the positive aspects related to the addition of m1. Important investigations conducted during this pandemic have but demonstrated that inactivated and mRNA-based vaccines temporarily interfere with IFN signaling.
N1-methyl-pseudouridine-containing COVID mRNA shots SUPPRESS the immune system and STIMULATE the growth of cancer! https ://t. co/CwKD14ZQc9 pic. twitter. com/W530bWiVcK— Ned Nikolov, Ph. D. ( @NikolovScience ) April 16, 2024Prior reports stated cancer rates are expected to hit a record high this year. Per Axios: New cancer cases reported in the United States. S. are expected to top 2 million for the first time in 2024, driven in large part by a worrying rise in cancers among younger Americans, according to fresh American Cancer Society data. Significant improvements have been made in cancer survival, but some cancers are rising alarmingly as doctors continue to look into why they see more affluent younger patients. This demographic shift comes with mental, physical and financial burdens that are less popular with older patients, experts say. Patients under 50 are more likely to be insured, juggling career and caregiving responsibilities, and face a higher lifetime risk of treatment-related side effects like following cancers. For anyone, but especially for these younger patients who are living their lives and then immediately receive this life-changing diagnosis, Robin Mendelsohn, co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancers at Memorial Sloan Kettering, told Axios. Read the study at ScienceDirect. [[{“value”:”
According to a study published in the International Journal of Biological Macromolecules, modified mRNA in COVID-19 injections may help cancer development. “Mounting data indicates that these vaccines do not produce sterilizing immunity and leave people vulnerable to recurrent infection.” Researchers found that mRNA vaccines interfere with essential immunological pathways and impair early interferon signals. This inhibition, within the COVID-19 vaccine framework, ensures an adequate spike protein synthesis and reduced immune activation. Evidence is provided that adding 100 % of N1-methyl-pseudouridine (m1Ps) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development,” the researchers continued. “Evidence is provided that adding 100 % of N1-methyl-pseudouridine (m1Ps) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer… pic.twitter.com/kXKE2rXp4f — Chief Nerd (@TheChiefNerd) April 20, 2024 “Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100 % m1Ps modification, but rather ones with the lower percentage of m1Ps modification to avoid immune suppression,” the researchers wrote. The Epoch Times reports that modified and natural RNAs stimulate different responses within the body. Modified RNA produces more aberrant proteins and may contribute to cell genome instability. Modified RNA produces a less intense response in the body compared to natural RNA. This may have a wide range of implications for the body’s ability fight other infections and tumors. The authors cited several studies that found natural RNA stimulated the activity of type-1 Interferon, a key antitumor substance, and other immune chemicals. Modified RNA, on the other hand, stimulates a milder reaction and is associated with immunochemicals that promote tolerance to foreign RNA injections. In an earlier study, RNA containing modified Uridine failed to activate the pathway involved in detecting viral infection and fighting cancer. They also cited a paper by Ms. Kariko, Dr. Weismann that found mRNA modifications suppressed immune recognition as well as activation of immune cell. The authors claim that this was a two-edged blade, because of the wide-reaching immunological consequences. The review authors cited a study of mice in Thailand as a critical piece evidence. Researchers injected 100 percent modified RNA and natural mRNA into two groups of mice that had melanoma. The Thai researchers found when the body was injected with natural DNA, it had a stronger immune response. The prognosis for the melanoma-affected mice was also different. The mice group that did not receive modified RNA had a survival rate of 100 percent. In contrast, only half the mice in the group that received the modified uridine survived. The Thai researchers stated in their abstract that an mRNA vaccination induces type-1 Interferon production as well as downstream signals critical for controlling tumor growth. Modified RNA in COVID Vaccines May Contribute to Cancer Development: Review Researchers argue that modification to mRNA causes immune suppression that may contribute to cancer development.https://t.co/Q8qM0utXDi — The Epoch Times (@EpochTimes) April 22, 2024 BREAKING: A review in the International Journal of Biological Macromolecules has found that COVID-19 mRNA vaccines could aid cancer development. Researchers suggest that future clinical studies should avoid using certain mRNA vaccinations to avoid immune suppression. Wow. Dr. Simone Gold @drsimonegold April 16, 2024 ScienceDirect: m1Ps used in COVID-19 candidate vaccines. In 2020, m1Ps coded for the entire transmembrane (S) protein of SARS CoV-2. IVT generated a significant amount of SARS-CoV-2 spike mRNA modified with m1Ps. Pfizer’s mRNA vaccine was the first to be fully licensed after demonstrating a good safety record and a 95 % protection against the disease following a two-inoculation (intramuscular) protocol. Is m1Ps friend or foe for cancer? The creators of mRNA vaccines for SARS-CoV-2 only highlighted the positive aspects of m1Ps. It was important to reduce the disintegration and immunogenicity of this synthesized synthetic mRNA to avoid an excessively aggressive immune reaction. During this pandemic, however, it was shown that inactivated and mRNA-based vaccines temporarily disrupt IFN signals.The COVID mRNA shots containing N1-methyl-pseudouridine SUPPRESS the immune system and STIMULATE cancer growth! https://t.co/CwKD14ZQc9 pic.twitter.com/W530bWiVcK — Ned Nikolov, Ph.D. (@NikolovScience) April 16, 2024 Prior reports stated cancer rates are expected to hit a record high this year. According to Axios, new cancer diagnoses are expected to reach 2 million in 2024 for the first time, largely due to an alarming rise in cancers among young Americans. Cancer survival has improved dramatically, but some cancers are on the rise. Doctors are also trying to figure out what is causing this increase in young cancer patients. Experts say that this demographic shift is accompanied by psychological, physical, and financial burdens, which are less common among older patients. Patients under 50 years old are more likely to lack insurance, be juggling caregiving and career responsibilities, as well as face a greater lifetime risk of treatment related side effects, such a second cancer. “It is overwhelming for anyone, but it is especially so for these younger patients, who are living their lives and suddenly receive this life-altering diagnoses and don’t know what to do,” Robin Mendelsohn told Axios. You can read the study on ScienceDirect.
“}]]
